Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2005 1
2007 1
2009 1
2010 1
2011 2
2013 5
2014 8
2015 3
2016 2
2018 2
2019 3
2020 6
2021 5
2022 5
2023 12
2024 7
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for s main zou d
Search for S Maninzou D instead (1 results)
Drug resistance in ovarian cancer: from mechanism to clinical trial.
Wang L, Wang X, Zhu X, Zhong L, Jiang Q, Wang Y, Tang Q, Li Q, Zhang C, Wang H, Zou D. Wang L, et al. Among authors: zou d. Mol Cancer. 2024 Mar 28;23(1):66. doi: 10.1186/s12943-024-01967-3. Mol Cancer. 2024. PMID: 38539161 Free PMC article. Review.
We reviewed the literature regarding various drug resistance mechanisms in ovarian cancer and found that the main resistance mechanisms are as follows: abnormalities in transmembrane transport, alterations in DNA damage repair, dysregulation of cancer-associated signaling …
We reviewed the literature regarding various drug resistance mechanisms in ovarian cancer and found that the main resistance mechanis …
Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Phase 3 Randomized Clinical Trial.
Li N, Zhu J, Yin R, Wang J, Pan L, Kong B, Zheng H, Liu J, Wu X, Wang L, Huang Y, Wang K, Zou D, Zhao H, Wang C, Lu W, Lin A, Lou G, Li G, Qu P, Yang H, Zhang Y, Cai H, Pan Y, Hao M, Liu Z, Cui H, Yang Y, Yao S, Zhen X, Hang W, Hou J, Wang J, Wu L. Li N, et al. Among authors: zou d. JAMA Oncol. 2023 Sep 1;9(9):1230-1237. doi: 10.1001/jamaoncol.2023.2283. JAMA Oncol. 2023. PMID: 37440217 Free PMC article. Clinical Trial.
INTERVENTIONS: Patients were randomized 2:1 to receive niraparib or placebo with ISD (200 mg/d for those with a body weight of <77 kg and/or platelet count of <150 103/muL [to convert to 109/muL, multiply by 1] at baseline; 300 mg/d otherwise) stratified by germline BRCA va …
INTERVENTIONS: Patients were randomized 2:1 to receive niraparib or placebo with ISD (200 mg/d for those with a body weight of <77 kg and …
ABCG2 plays a central role in the dysregulation of 25-hydrovitamin D in Crohn's disease.
Peng J, Song X, Zhu F, Zhang C, Xia J, Zou D, Liu J, Yin F, Yin L, Guo H, Liu J. Peng J, et al. Among authors: zou d. J Nutr Biochem. 2023 Aug;118:109360. doi: 10.1016/j.jnutbio.2023.109360. Epub 2023 Apr 21. J Nutr Biochem. 2023. PMID: 37087072
Vitamin D (VD) deficiency, as indicated by the main circulating form of VD metabolite 25-hydrovitamin D(3) (25(OH)D(3)), in patients with Crohn's disease (CD) has been well documented, but the reasons for this remain unclear. ...
Vitamin D (VD) deficiency, as indicated by the main circulating form of VD metabolite 25-hydrovitamin D(3) (25(OH)D(3)), in patients …
A Randomized Controlled Clinical Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea.
Hedner J, Stenlöf K, Zou D, Hoff E, Hansen C, Kuhn K, Lennartz P, Grote L. Hedner J, et al. Among authors: zou d. Am J Respir Crit Care Med. 2022 Jun 15;205(12):1461-1469. doi: 10.1164/rccm.202109-2043OC. Am J Respir Crit Care Med. 2022. PMID: 35202553 Clinical Trial.
Methods: A 4-week double-blind, randomized, placebo-controlled dose-guiding trial was conducted in patients with moderate and/or severe OSA not tolerating positive airway pressure treatment. Measurements and Main Results: Intermittent paresthesia was reported by 79%, 67%, …
Methods: A 4-week double-blind, randomized, placebo-controlled dose-guiding trial was conducted in patients with moderate and/or severe OSA …
The roles of ERIANIN in tumor and innate immunity and its' perspectives in immunotherapy.
Yang Z, Liu R, Qiu M, Mei H, Hao J, Song T, Zhao K, Zou D, Wang H, Gao M. Yang Z, et al. Among authors: zou d. Front Immunol. 2023 Apr 28;14:1170754. doi: 10.3389/fimmu.2023.1170754. eCollection 2023. Front Immunol. 2023. PMID: 37187758 Free PMC article. Review.
In 2022, the 14th Five-Year Plan for the Development of Traditional Chinese Medicine was released, aiming to enhance traditional Chinese medicine health services and improve policies and systems for high-quality traditional Chinese medicinal development by 2025. ERIANIN, the m …
In 2022, the 14th Five-Year Plan for the Development of Traditional Chinese Medicine was released, aiming to enhance traditional Chinese med …
Single-cell and spatial transcriptomics reveals that PTPRG activates the m(6)A methyltransferase VIRMA to block mitophagy-mediated neuronal death in Alzheimer's disease.
Zou D, Huang X, Lan Y, Pan M, Xie J, Huang Q, Zeng J, Zou C, Pei Z, Zou C, Mao Y, Luo J. Zou D, et al. Pharmacol Res. 2024 Mar;201:107098. doi: 10.1016/j.phrs.2024.107098. Epub 2024 Feb 5. Pharmacol Res. 2024. PMID: 38325728 Free article.
Neuronal death is one of the key pathologies in Alzheimer's disease (AD). How neuronal death begins in AD is far from clear, so clarifying this process may help develop effective therapies. ...Additionally, spatial transcriptomic data of coronal sections from 6 App(NL-G-F) …
Neuronal death is one of the key pathologies in Alzheimer's disease (AD). How neuronal death begins in AD is far from clear, so clari …
The placebo effect in pharmacological treatment of obstructive sleep apnea, a systematic review and meta-analysis.
Hoff E, Zou D, Grote L, Stenlöf K, Hedner J. Hoff E, et al. Among authors: zou d. Sleep Med. 2023 Jun;106:1-7. doi: 10.1016/j.sleep.2023.03.019. Epub 2023 Mar 22. Sleep Med. 2023. PMID: 37023489 Free article.
Studies were generally small (median n = 14), with 78% men, baseline AHI range 9-74 events/h and treatment duration range 1-120 days. Meta-analyses were conducted for main outcomes. Mean change of the primary outcome, AHI, was -0.84 (95% CI -2.98 to 1.30); mSaO(2) and ODI …
Studies were generally small (median n = 14), with 78% men, baseline AHI range 9-74 events/h and treatment duration range 1-120 days. Meta-a …
Hepatic microcirculatory disturbance in liver diseases: intervention with traditional Chinese medicine.
Liu P, Liang WL, Huang RT, Chen XX, Zou DH, Kurihara H, Li YF, Xu YH, Ouyang SH, He RR. Liu P, et al. Among authors: zou dh. Front Pharmacol. 2024 Jul 23;15:1399598. doi: 10.3389/fphar.2024.1399598. eCollection 2024. Front Pharmacol. 2024. PMID: 39108760 Free PMC article. Review.
An intricate interplay exists between hepatic microcirculatory disturbance and the manifestation of pathological features in diverse liver diseases. This review updates the main characteristics of hepatic microcirculatory disturbance, including hepatic sinusoidal capillari …
An intricate interplay exists between hepatic microcirculatory disturbance and the manifestation of pathological features in diverse liver d …
Chinese Expert Consensus on the Clinical Diagnosis and Management of Statin Intolerance.
Li JJ, Dou KF, Zhou ZG, Zhao D, Ye P, Chen H, Chen ZY, Peng DQ, Guo YL, Wu NQ, Qian J; contributing experts. Li JJ, et al. Clin Pharmacol Ther. 2024 May;115(5):954-964. doi: 10.1002/cpt.3213. Epub 2024 Mar 8. Clin Pharmacol Ther. 2024. PMID: 38459425 Review.
Although statins are well-tolerated generally, however, the report of statin-related adverse event and statin intolerance are common in China, which results in insufficient use of statins and poor adherence. The main reason may be attributed to confusions or misconceptions …
Although statins are well-tolerated generally, however, the report of statin-related adverse event and statin intolerance are common in Chin …
Mongolian folk medicine--from traditional practice to scientific development.
Zhang CH, Zhao ZY, Hasi BT, Li ZH, Wu MM, Zou DZ, Li MH. Zhang CH, et al. Among authors: zou dz. Zhongguo Zhong Yao Za Zhi. 2015 Jul;40(13):2492-5. Zhongguo Zhong Yao Za Zhi. 2015. PMID: 26697668 Review.
Mongolian folk medicine, the important part of Mongolian medicine, is the main means, method and weapon of disease prevention, treatment and health care. Mongolian materia medicas are the important literatures of guiding the healthy development of the modern Mongolian medi …
Mongolian folk medicine, the important part of Mongolian medicine, is the main means, method and weapon of disease prevention, treatm …
67 results